Skip to main content
Top
Gepubliceerd in: Kind & Adolescent Praktijk 1/2018

01-03-2018 | Werk in uitvoering

Is risperidon bij probleemgedrag effectief?

Auteurs: Lotte Ramerman, Pieter Hoekstra, Gerda Kuijper

Gepubliceerd in: Kind & Adolescent Praktijk | Uitgave 1/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Kinderen en jeugdigen met een verstandelijke beperking en gedragsproblemen slikken vaak langdurig risperidon. Maar is dat wel effectief? En wat gebeurt er als zij deze medicijnen afbouwen?
Literatuur
go back to reference Aman, M.G., De Smedt, G., Derivan, A., Lyons, B., Findling, R.L., & Risperidone Disruptive Behavior Study Group. (2014). Double-blind, placebo-controlled study of Risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Aman, M.G., De Smedt, G., Derivan, A., Lyons, B., Findling, R.L., & Risperidone Disruptive Behavior Study Group. (2014). Double-blind, placebo-controlled study of Risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.
go back to reference de Kuijper, G., Evenhuis, H.M., Minderaa, R., & Hoekstra, P.J. (2014). Effects of controlled discontinuation of long-term used antipsychotics for behavioural symptoms in individuals with intellectual disability. Journal of Intellectual Disability Research, 58(1), 71-83. de Kuijper, G., Evenhuis, H.M., Minderaa, R., & Hoekstra, P.J. (2014). Effects of controlled discontinuation of long-term used antipsychotics for behavioural symptoms in individuals with intellectual disability. Journal of Intellectual Disability Research, 58(1), 71-83.
go back to reference de Kuijper, G., Hoekstra, P., Visser, F., Scholte, F., Penning, C., & Evenhuis, H. (2010). Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: Prevalence and reasons for prescription. Journal of Intellectual Disability Research, 54(7), 659-667.CrossRef de Kuijper, G., Hoekstra, P., Visser, F., Scholte, F., Penning, C., & Evenhuis, H. (2010). Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: Prevalence and reasons for prescription. Journal of Intellectual Disability Research, 54(7), 659-667.CrossRef
go back to reference Deb, S., & Unwin, G.L. (2007). Psychotropic medication for behaviour problems in people with intellectual disability: A review of the current literature. Current Opinion in Psychiatry, 20(5), 461-466.CrossRef Deb, S., & Unwin, G.L. (2007). Psychotropic medication for behaviour problems in people with intellectual disability: A review of the current literature. Current Opinion in Psychiatry, 20(5), 461-466.CrossRef
go back to reference Grey, I.M., & Hastings, R.P. (2005). Evidence-based practices in intellectual disability and behaviour disorders. Current Opinion in Psychiatry, 18(5), 469-475.CrossRef Grey, I.M., & Hastings, R.P. (2005). Evidence-based practices in intellectual disability and behaviour disorders. Current Opinion in Psychiatry, 18(5), 469-475.CrossRef
go back to reference Hellings, J.A., Zarcone, J.R., Valdovinos, M.G., Reese, R.M., Gaughan, E., & Schroeder, S.R. (2005). Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders. Journal of Child & Adolescent Psychopearmacology, 15(6), 885-892.CrossRef Hellings, J.A., Zarcone, J.R., Valdovinos, M.G., Reese, R.M., Gaughan, E., & Schroeder, S.R. (2005). Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders. Journal of Child & Adolescent Psychopearmacology, 15(6), 885-892.CrossRef
go back to reference Matson, J.L., & Mahan, S. (2010). Antipsychotic drug side effects for persons with intellectual disability. Research in Developmental Disabilities, 31(6), 1570-1576.CrossRef Matson, J.L., & Mahan, S. (2010). Antipsychotic drug side effects for persons with intellectual disability. Research in Developmental Disabilities, 31(6), 1570-1576.CrossRef
go back to reference Ramerman, L., Kuijper, G. de, & Hoekstra, P.J. (2017). Adherence of clinicians to guidelines for the prescription of antipsychotic drugs to people with intellectual disabilities. Advances in Mental Health and Intellectual Disabilities, 11(3), 110-125.CrossRef Ramerman, L., Kuijper, G. de, & Hoekstra, P.J. (2017). Adherence of clinicians to guidelines for the prescription of antipsychotic drugs to people with intellectual disabilities. Advances in Mental Health and Intellectual Disabilities, 11(3), 110-125.CrossRef
go back to reference Scheifes, A., Walraven, S., Stolker, J.J., Nijman, H.L., Egberts, T.C., & Heerdink, E.R. (2016). Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs. Research in Developmental Disabilities, 49, 13-21.CrossRef Scheifes, A., Walraven, S., Stolker, J.J., Nijman, H.L., Egberts, T.C., & Heerdink, E.R. (2016). Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs. Research in Developmental Disabilities, 49, 13-21.CrossRef
go back to reference Tyrer, P., Oliver-Africano, P.C., Ahmed, Z., Bouras, N., Cooray, S., Deb, S., Crawford, M. (2008). Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: A randomised controlled trial. Lancet, 371(9606), 57-63.CrossRef Tyrer, P., Oliver-Africano, P.C., Ahmed, Z., Bouras, N., Cooray, S., Deb, S., Crawford, M. (2008). Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: A randomised controlled trial. Lancet, 371(9606), 57-63.CrossRef
Metagegevens
Titel
Is risperidon bij probleemgedrag effectief?
Auteurs
Lotte Ramerman
Pieter Hoekstra
Gerda Kuijper
Publicatiedatum
01-03-2018
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Kind & Adolescent Praktijk / Uitgave 1/2018
Print ISSN: 1571-4136
Elektronisch ISSN: 1875-7065
DOI
https://doi.org/10.1007/s12454-018-0011-8

Andere artikelen Uitgave 1/2018

Kind & Adolescent Praktijk 1/2018 Naar de uitgave

Gezien en Gelezen

Gezien en Gelezen

Uit de Praktijk

Een wereld van papier